We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.48%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.21B
AUM Growth
+$330M
Cap. Flow
+$275M
Cap. Flow %
22.73%
Top 10 Hldgs %
36.41%
Holding
4,516
New
1,790
Increased
1,264
Reduced
722
Closed
680

Sector Composition

Rank Sector Weight
1 Financials 6.31%
2 Technology 5.59%
3 Industrials 5.06%
4 Consumer Discretionary 3.68%
5 Healthcare 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCBG icon
2576
Capital City Bank Group
CCBG
$897M
$25K ﹤0.01%
+1,073
New +$22.6K
CRSP icon
2577
CRISPR Therapeutics
CRSP
$5.02B
$25K ﹤0.01%
+1,387
New +$25.1K
CYTK icon
2578
Cytokinetics
CYTK
$10.8B
$25K ﹤0.01%
1,701
+472
+38% +$6.45K
DVY icon
2579
iShares Select Dividend ETF
DVY
$23.5B
$25K ﹤0.01%
+264
New +$24.4K
FC icon
2580
Franklin Covey
FC
$241M
$25K ﹤0.01%
1,265
+1,165
+1,165% +$21.7K
FORR icon
2581
Forrester Research
FORR
$232M
$25K ﹤0.01%
+591
New +$23.8K
LAMR icon
2582
Lamar Advertising Co
LAMR
$16.2B
$25K ﹤0.01%
367
+108
+42% +$7.31K
LH icon
2583
Labcorp
LH
$25.5B
$25K ﹤0.01%
+192
New +$25.6K
LULU icon
2584
lululemon athletica
LULU
$14.2B
$25K ﹤0.01%
+401
New +$24.2K
NAII icon
2585
Natural Alternatives International
NAII
$15.3M
$25K ﹤0.01%
2,360
+1,751
+288% +$18.1K
PUI icon
2586
Invesco Dorsey Wright Utilities Momentum ETF
PUI
$54.4M
$25K ﹤0.01%
912
+810
+794% +$23K
SGC icon
2587
Superior Group of Companies
SGC
$228M
$25K ﹤0.01%
+1,108
New +$24.6K
SMBK icon
2588
SmartFinancial
SMBK
$897M
$25K ﹤0.01%
1,038
+930
+861% +$22.2K
SQNS
2589
Sequans Communications SA
SQNS
$41.6M
$25K ﹤0.01%
80
+29
+57% +$9.29K
SYY icon
2590
Sysco
SYY
$40.4B
$25K ﹤0.01%
468
+446
+2,027% +$23.2K
TEL icon
2591
TE Connectivity
TEL
$62.9B
$25K ﹤0.01%
+306
New +$24.6K
TS icon
2592
Tenaris
TS
$26.8B
$25K ﹤0.01%
887
+650
+274% +$19K
UNM icon
2593
Unum
UNM
$14.2B
$25K ﹤0.01%
+480
New +$23.4K
DXYN
2594
DELISTED
Dixie Group Inc
DXYN
$25K ﹤0.01%
6,327
+5,316
+526% +$22.4K
TESS
2595
DELISTED
Tessco Technologies Inc
TESS
$25K ﹤0.01%
+2,081
New +$27.7K
ACOR
2596
DELISTED
Acorda Therapeutics
ACOR
$25K ﹤0.01%
+9
New +$23.7K
CNBKA
2597
DELISTED
Century Bancorp Inc/Mass
CNBKA
$25K ﹤0.01%
307
-11
-3% -$743
KIN
2598
DELISTED
Kindred Biosciences, Inc.
KIN
$25K ﹤0.01%
+3,266
New +$24.5K
AKRX
2599
DELISTED
Akorn Inc
AKRX
$25K ﹤0.01%
742
+642
+642% +$21.3K
INXN
2600
DELISTED
Interxion Holding N.V.
INXN
$25K ﹤0.01%
+499
New +$24.4K

Similar funds

Tower Research Capital (TRC)'s Q3 2017 Portfolio in Review

As of Q3 2017, Tower Research Capital (TRC) held 4,516 positions worth $1.21B, up 37% from $881M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Tower Research Capital (TRC) deployed $275M of net new capital in Q3 2017, opening 1,790 new positions and adding to 1,264 existing holdings. Its largest new stake was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.

By sector, the portfolio is most concentrated in Financials at 6.3% of assets, up from 2.1% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $60M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2017 buy was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $135M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2017 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $60M.
  • Tower Research Capital (TRC) fully exited State Street Consumer Discretionary Select Sector SPDR ETF in Q3 2017, selling an estimated $17.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 36% of its $1.21B portfolio in Q3 2017.
  • Tower Research Capital (TRC) opened 1,790 new positions and closed 680 in Q3 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 37% quarter-over-quarter to $1.21B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2017, filed 14 Nov 2017.